Santo Therapeutics is established by experienced genetic scientists and biotechnological experts from University of Cambridge, University College London, etc. Technical team are excellent in the development and manufacture of novel viral vector and manufacture.
With our next generation viral vector platforms, Santo Therapeutics is committed to develop in house Pipeline programs to treat rare diseases with highly unmet medical need worldwide. The current projects involves in neurodegenerative and neuro-oncological diseases. Also, we are interested in partnerships with biopharmaceutical players in other disease areas.
Company Details
- Employees
- 3
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.Santobiopharma.com
- Keywords
- London.
Santo Therapeutics Questions
Santo Therapeutics's website is http://www.Santobiopharma.com
Santo Therapeutics's LinkedIn profile is https://www.linkedin.com/company/santo-therapeutics
Santo Therapeutics has
3 employees.
View email and phone details for 3
employees at Santo Therapeutics.
Santo Therapeutics's industry is
Biotechnology Research
Santo Therapeutics's top competitors are
The Beaconside Group,
Cambridge Cognition,
Maxion Therapeutics,
Kumuda,
Stevenage Bioscience Catalyst,
Panv, Inc.,
The Talentbranch Group,
Mosaic Tx,
Destiny Pharma Limited - In Administration,
Beyond Lab.
Santo Therapeutics's categories are Biotechnology Research
